Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Forensic Genomics Market, by Application
1.4.2 LAMEA Forensic Genomics Market, by Product
1.4.3 LAMEA Forensic Genomics Market, by Method
1.4.4 LAMEA Forensic Genomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Forensic Genomics Market by Application
4.1 LAMEA Criminal Testing Market by Country
4.2 LAMEA Paternity & Familial Testing Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Forensic Genomics Market by Product
5.1 LAMEA Kits & Consumables Market by Country
5.2 LAMEA Analyzers & Sequencers Market by Country
5.3 LAMEA Software Market by Country
Chapter 6. LAMEA Forensic Genomics Market by Method
6.1 LAMEA Capillary Electrophoresis Market by Country
6.2 LAMEA Next-generation Sequencing Market by Country
6.3 LAMEA PCR Amplification Market by Country
Chapter 7. LAMEA Forensic Genomics Market by Country
7.1 Brazil Forensic Genomics Market
7.1.1 Brazil Forensic Genomics Market by Application
7.1.2 Brazil Forensic Genomics Market by Product
7.1.3 Brazil Forensic Genomics Market by Method
7.2 Argentina Forensic Genomics Market
7.2.1 Argentina Forensic Genomics Market by Application
7.2.2 Argentina Forensic Genomics Market by Product
7.2.3 Argentina Forensic Genomics Market by Method
7.3 UAE Forensic Genomics Market
7.3.1 UAE Forensic Genomics Market by Application
7.3.2 UAE Forensic Genomics Market by Product
7.3.3 UAE Forensic Genomics Market by Method
7.4 Saudi Arabia Forensic Genomics Market
7.4.1 Saudi Arabia Forensic Genomics Market by Application
7.4.2 Saudi Arabia Forensic Genomics Market by Product
7.4.3 Saudi Arabia Forensic Genomics Market by Method
7.5 South Africa Forensic Genomics Market
7.5.1 South Africa Forensic Genomics Market by Application
7.5.2 South Africa Forensic Genomics Market by Product
7.5.3 South Africa Forensic Genomics Market by Method
7.6 Nigeria Forensic Genomics Market
7.6.1 Nigeria Forensic Genomics Market by Application
7.6.2 Nigeria Forensic Genomics Market by Product
7.6.3 Nigeria Forensic Genomics Market by Method
7.7 Rest of LAMEA Forensic Genomics Market
7.7.1 Rest of LAMEA Forensic Genomics Market by Application
7.7.2 Rest of LAMEA Forensic Genomics Market by Product
7.7.3 Rest of LAMEA Forensic Genomics Market by Method
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Agilent Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Neogen Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Eurofins Scientific Group (Eurofins Discovery)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Gene by Gene, Ltd.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Verogen, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Acquisition and Mergers:
Unique Offerings 